Xtandi 40 MG tablet 120S
Ended Awarded
- Contract number
- SPE2DB25FYBGQ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,170
Award facts
- Contract value 100% obligated
- $4,169.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
On August 1, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $4,169.59 to DMS Pharmaceutical Group Inc. for the supply of Xtandi 40 mg tablets (120-count units). This firm fixed-price delivery order is associated with DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a $499.999 billion contract vehicle valid through November 2026 that enables the agency to issue delivery orders for comprehensive pharmaceutical products supporting military health facilities worldwide. The contract utilizes no set-aside designation, allowing DMS Pharmaceutical Group to compete on its merits as a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois.
DMS Pharmaceutical Group Inc., registered in SAM.gov since 2001, serves as a critical supplier within the federal pharmaceutical supply chain, specializing in the distribution of branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare sites nationally. The company's extensive contract portfolio with the DLA demonstrates its capacity to deliver diverse pharmaceutical products ranging from oncology treatments to specialty medications. With the ultimate completion date set for August 4, 2025, and performance to be executed in Park Ridge, Illinois, this delivery order represents a routine procurement under the established IDC framework supporting ongoing medical supply requirements for military healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FYBGQ?
SPE2DB25FYBGQ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 1, 2025.
How much is contract SPE2DB25FYBGQ worth?
The government has obligated $4,170 on SPE2DB25FYBGQ.
Is contract SPE2DB25FYBGQ an order under another contract?
Yes. SPE2DB25FYBGQ is a delivery order under SPE2DB24D9313, an indefinite delivery contract.
Was contract SPE2DB25FYBGQ competed?
The extent of competition for SPE2DB25FYBGQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award